Summary

Expands and clarifies what Medicare pays for when patients receive home infusion therapy. It adds pharmacy services, lets nurse practitioners and physician assistants set and review plans of care, covers certain IV anti‑infective drugs given without a pump, and bundles related supplies into the home infusion payment. Updates how and how much Medicare pays: creates a transitional payment policy from 2026 through 2029 and establishes a 50% payment for home‑infusion days when the supplier is not physically present. Most changes begin January 1, 2026.

Key Points

• Adds pharmacy services to the scope of Medicare home infusion therapy.
• Lets nurse practitioners and physician assistants establish and review home infusion plans of care.
• Creates a new category for non‑pump IV anti‑infective drugs given at home and clarifies related supplier payments.
• Introduces a transitional payment policy from 2026 through 2029.
• Establishes a 50% payment rate for days when the supplier is not physically present.
• Bundles certain home infusion supplies into the therapy payment (no separate DME payment when billed with the same drug/day).
• All key provisions take effect on January 1, 2026 (with the transitional period through 2029).

Categories & Tags